INT109769

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.49
First Reported 2003
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 3
Total Number 3
Disease Relevance 0.42
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

transport (ATP5J) mitochondrion (ATP5J) small molecule metabolic process (ATP5J)
transmembrane transporter activity (ATP5J) ATPase activity (ATP5J)
Anatomy Link Frequency
endothelial cells 2
ATP5J (Homo sapiens)
Pain Link Frequency Relevance Heat
anesthesia 2 25.00 Low Low
Angina 2 5.00 Very Low Very Low Very Low
Bioavailability 2 5.00 Very Low Very Low Very Low
peptic ulcer disease 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Stress 2 99.60 Very High Very High Very High
Pressure And Volume Under Development 23 93.88 High High
Hypertension 2 5.00 Very Low Very Low Very Low
Cv General 3 Under Development 2 5.00 Very Low Very Low Very Low
Disease 1 5.00 Very Low Very Low Very Low
Ulcers 1 5.00 Very Low Very Low Very Low
Tumor Necrosis Factor Receptor-associated Periodic Syndrome 1 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
CF-6, which is localized to the surface of endothelial cells (ECs) and released by shear stress, has been implicated as an endogenous vasoconstrictor.
Localization (localized) of CF-6 in endothelial cells associated with stress
1) Confidence 0.49 Published 2003 Journal Regul. Pept. Section Abstract Doc Link 12686462 Disease Relevance 0.10 Pain Relevance 0
CF-6, which is localized to the surface of endothelial cells (ECs) and released by shear stress, has been implicated as an endogenous vasoconstrictor.
Localization (released) of CF-6 in endothelial cells associated with stress
2) Confidence 0.49 Published 2003 Journal Regul. Pept. Section Abstract Doc Link 12686462 Disease Relevance 0.10 Pain Relevance 0
This gel layer was responsible for maintenance of the matrix integrity, avoidance of burst effect and the slow release of the drug from this formulation (F6).
Localization (release) of F6
3) Confidence 0.02 Published 2010 Journal Scientia Pharmaceutica Section Body Doc Link PMC3007615 Disease Relevance 0.22 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox